+-------------------------------+---------+------------+--------------+---------+ 
|                               |         |            |              |         | 
+-------------------------------+---------+------------+--------------+---------+ 
|                               |         |            |              |         | 
+-------------------------------+---------+------------+--------------+---------+ 
| Segment liabilities           |   7,397 |        962 |           63 |   8,422 | 
+-------------------------------+---------+------------+--------------+---------+ 
| Unallocated liabilities       |         |            |              |   6,688 | 
+-------------------------------+---------+------------+--------------+---------+ 
|                               |         |            |              |         | 
+-------------------------------+---------+------------+--------------+---------+ 
| Total liabilities             |         |            |              |  15,110 | 
+-------------------------------+---------+------------+--------------+---------+ 
|                               |         |            |              |         | 
+-------------------------------+---------+------------+--------------+---------+ 
A geographical analysis of revenue by destination is as follows: 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            | Unaudited | Unaudited | Audited | 
|                                            |  6 months |  6 months |      12 | 
|                                            |      2010 |      2009 |  months | 
|                                            |           |           |    2009 | 
|                                            |   GBP'000 |   GBP'000 |         | 
|                                            |           |           | GBP'000 | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| United Kingdom                             |    15,657 |    15,573 |  32,171 | 
+--------------------------------------------+-----------+-----------+---------+ 
| Europe (excluding UK)                      |       821 |       743 |   1,772 | 
+--------------------------------------------+-----------+-----------+---------+ 
| Rest of world                              |       277 |       236 |     659 | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |    16,755 |    16,552 |  34,602 | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
 
 
5.      Earnings per share 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            | Unaudited | Unaudited | Audited | 
|                                            |  6 months |  6 months |      12 | 
|                                            |      2010 |      2009 |  months | 
|                                            |           |           |    2009 | 
|                                            |   GBP'000 |   GBP'000 |         | 
|                                            |           |           | GBP'000 | 
+--------------------------------------------+-----------+-----------+---------+ 
| Earnings                                   |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Earnings for the purposes of basic and     |           |           |         | 
| diluted earning per share (profit for the  |           |           |         | 
| period attributable to equity holders of   |      (32) |       427 |     602 | 
| the parent)                                |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Add back:                                  |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Impairment of goodwill                     |         - |         - |     405 | 
+--------------------------------------------+-----------+-----------+---------+ 
| Amortisation of intangible assets          |           |           |         | 
| recognised on acquisition, net of deferred |        67 |        67 |     136 | 
| tax credit                                 |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Charge for share options in issue          |        14 |         5 |      28 | 
+--------------------------------------------+-----------+-----------+---------+ 
| One off items, net of corporation tax      |        70 |         - |    (74) | 
| impact                                     |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Earnings for the purposes of Adjusted EPS  |       119 |       499 |   1,097 | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                     Number |      '000 |      '000 |    '000 | 
+--------------------------------------------+-----------+-----------+---------+ 
| Number of shares                           |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
| Weighted average number of ordinary shares |           |           |         | 
| for the purposes of basic and diluted      |           |           |         | 
| earnings per share                         |   175,985 |   175,985 | 175,985 | 
+--------------------------------------------+-----------+-----------+---------+ 
|                                            |           |           |         | 
+--------------------------------------------+-----------+-----------+---------+ 
               There is no dilutive effect from the share options in issue. 
 
6.      Analysis of Net Debt 
 
+------------------------------+------------+----------+----------+----------+ 
|                              |            |          |          |          | 
|                              |         31 |     Cash | Non-cash |  30 June | 
|                              |   December |     flow |  changes |     2010 | 
|                              |       2009 |          |  GBP'000 |  GBP'000 | 
|                              |    GBP'000 |  GBP'000 |          |          | 
+------------------------------+------------+----------+----------+----------+ 
| Finance leases - current     |       (57) |       29 |        - |     (28) | 
+------------------------------+------------+----------+----------+----------+ 
| Banks loan - current         |      (967) |  (4,590) |        2 |  (5,555) | 
+------------------------------+------------+----------+----------+----------+ 
| Bank loan - non-current      |    (4,967) |    4,093 |       17 |    (857) | 
+------------------------------+------------+----------+----------+----------+ 
|                              |            |          |          |          | 
+------------------------------+------------+----------+----------+----------+ 
| Debt                         |    (5,991) |    (468) |       19 |  (6,440) | 
+------------------------------+------------+----------+----------+----------+ 
| Cash and cash equivalents    |        961 |     (26) |        - |      935 | 
+------------------------------+------------+----------+----------+----------+ 
|                              |            |          |          |          | 
+------------------------------+------------+----------+----------+----------+ 
| Net debt                     |    (5,030) |    (494) |       19 |  (5,505) | 
+------------------------------+------------+----------+----------+----------+ 
|                              |            |          |          |          | 
+------------------------------+------------+----------+----------+----------+ 
 
On 23 April 2010 the existing term loan and revolver facility with KBC Bank were 
replaced with an asset backed lending facility with KBC Business Capital, a 
division of KBC Bank. 
The new facility is structured as follows: 
·      An invoice discount facility to a maximum of GBP5million at an interest 
rate of 2% above base rate 
·      A stock finance facility to a maximum of GBP1.5million at an interest 
rate of 2.25% above base rate 
·      A term loan for GBP1.5million with equal monthly repayments over 36 
months at an interest rate of 2.5% above base rate 
 
INDEPENDENT REVIEW REPORT TO NEUTRAHEALTH PLC 
 
Introduction 
We have been engaged by the Company to review the condensed set of financial 
statements in the  interim financial report for the six months ended 30 June 
2010 which comprises the consolidated statement of comprehensive income, 
consolidated balance sheet, consolidated statement of changes in equity, 
consolidated cash flow statement and related notes.  We have read the other 
information contained in the interim financial report and considered whether it
Neutrahealth (LSE:NUT)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Neutrahealth Charts.
Neutrahealth (LSE:NUT)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Neutrahealth Charts.